One explanation for why downstream gonadotropin protocol changes during IVF commonly arrive too late to have significant effects is that embryo development actually begins during oogenesis. Thus, efforts to modify the chromosomal status of blastocysts must address the ovarian milieu well in advance of follicular recruitment. A 42 year old woman with primary infertility of 3 year duration attended with her partner. Five previous IVF cycles had produced 20 embryos, but all had genetic abnormalities and no embryo transfer was performed.
A three, month interval elapsed before commencing her final IVF; for this cycle a GnRHantagonist was again utilized but gonadotropin doses were adjusted ( 
Conflict of interest
ESS holds a provisional U.S. patent for process & treatment using ovarian platelet rich . From the second cycle, one 46, XY blastocyst was produced which was subsequently transferred and resulted in a single (ongoing) intrauterine pregnancy.
